Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Amyl nitrite induced cerebral and coronary vasospasm.

Nicol LM, Mills NL, Starkey IR.

QJM. 2011 Jan;104(1):83-4. doi: 10.1093/qjmed/hcq162. Epub 2010 Sep 15. No abstract available.

PMID:
20843773
2.

Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies.

Hildick-Smith D, de Belder AJ, Cooter N, Curzen NP, Clayton TC, Oldroyd KG, Bennett L, Holmberg S, Cotton JM, Glennon PE, Thomas MR, Maccarthy PA, Baumbach A, Mulvihill NT, Henderson RA, Redwood SR, Starkey IR, Stables RH.

Circulation. 2010 Mar 16;121(10):1235-43. doi: 10.1161/CIRCULATIONAHA.109.888297. Epub 2010 Mar 1.

PMID:
20194880
3.

Drug-eluting stents versus bare-metal stents for off-label indications: a propensity score-matched outcome study.

Austin D, Oldroyd KG, McConnachie A, Slack R, Eteiba H, Flapan AD, Jennings KP, Northcote RJ, Pell AC, Starkey IR, Pell JP.

Circ Cardiovasc Interv. 2008 Aug;1(1):45-52. doi: 10.1161/CIRCINTERVENTIONS.108.769042.

PMID:
20031654
4.

Hospital and operator variations in drug-eluting stent use: a multi-level analysis of 5967 consecutive patients in Scotland.

Austin D, Oldroyd KG, McConnachie A, Slack R, Eteiba H, Flapan AD, Jennings KP, Northcote RJ, Pell AC, Starkey IR, Pell JP.

J Public Health (Oxf). 2008 Jun;30(2):186-93. doi: 10.1093/pubmed/fdn016. Epub 2008 Feb 29.

PMID:
18310140
5.

Reduced vascular complications and length of stay with transradial rescue angioplasty for acute myocardial infarction.

Cruden NL, Teh CH, Starkey IR, Newby DE.

Catheter Cardiovasc Interv. 2007 Nov 1;70(5):670-5.

PMID:
17563094
6.

Unemployment and deprivation are associated with a poorer outcome following percutaneous coronary angioplasty.

Leslie SJ, Rysdale J, Lee AJ, Eteiba H, Starkey IR, Pell J, Denvir MA.

Int J Cardiol. 2007 Nov 15;122(2):168-9. Epub 2007 Jan 16.

PMID:
17234282
7.

Influence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary intervention.

Denvir MA, Lee AJ, Rysdale J, Walker A, Eteiba H, Starkey IR, Pell JP.

J Epidemiol Community Health. 2006 Dec;60(12):1085-8.

8.

Saphenous vein graft aneurysm.

Cruden NL, Turnbull C, Starkey IR.

Eur Heart J. 2007 May;28(9):1071. Epub 2006 Nov 6. No abstract available.

PMID:
17088315
9.

Effects of changing clinical practice on costs and outcomes of percutaneous coronary intervention between 1998 and 2002.

Denvir MA, Lee AJ, Rysdale J, Prescott RJ, Eteiba H, Starkey IR, Pell JP, Walker A.

Heart. 2007 Feb;93(2):195-9. Epub 2006 Jul 18.

10.

Variations in clinical decision-making between cardiologists and cardiac surgeons; a case for management by multidisciplinary teams?

Denvir MA, Pell JP, Lee AJ, Rysdale J, Prescott RJ, Eteiba H, Walker A, Mankad P, Starkey IR.

J Cardiothorac Surg. 2006 Mar 3;1:2.

11.

Hospital volume of throughput and periprocedural and medium-term adverse events after percutaneous coronary intervention: retrospective cohort study of all 17,417 procedures undertaken in Scotland, 1997-2003.

Burton KR, Slack R, Oldroyd KG, Pell AC, Flapan AD, Starkey IR, Eteiba H, Jennings KP, Northcote RJ, Hillis WS, Pell JP.

Heart. 2006 Nov;92(11):1667-72. Epub 2006 May 18.

12.

Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries.

Newman CM, Starkey I, Buller N, Seabra-Gomes R, Kirby S, Hettiarachchi J, Cumberland D, Hillis WS.

Eur J Clin Pharmacol. 2005 Nov;61(10):733-42. Epub 2005 Sep 8.

PMID:
16151760
13.
14.

Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE).

Carruthers KF, Dabbous OH, Flather MD, Starkey I, Jacob A, Macleod D, Fox KA; GRACE Investigators.

Heart. 2005 Mar;91(3):290-8.

15.

Comparing performance between coronary intervention centres requires detailed case-mix adjusted analysis.

Denvir MA, Lee AJ, Rysdale J, Prescott RJ, Eteiba H, Walker A, Starkey IR, Pell JP.

J Public Health (Oxf). 2004 Jun;26(2):177-84.

PMID:
15284323
16.

Comparison of survival following coronary artery bypass grafting vs. percutaneous coronary intervention in diabetic and non-diabetic patients: retrospective cohort study of 6320 procedures.

Pell JP, Pell AC, Jeffrey RR, Jennings K, Oldroyd K, Eteiba H, Hogg KJ, Murday A, Faichney A, Colquhoun I, Berg G, Starkey IR, Flapan A, Mankad P.

Diabet Med. 2004 Jul;21(7):790-2.

PMID:
15209776
17.

Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.

Murchie AI, Davis B, Isel C, Afshar M, Drysdale MJ, Bower J, Potter AJ, Starkey ID, Swarbrick TM, Mirza S, Prescott CD, Vaglio P, Aboul-ela F, Karn J.

J Mol Biol. 2004 Feb 20;336(3):625-38.

PMID:
15095977
18.
19.

Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".

Davis B, Afshar M, Varani G, Murchie AI, Karn J, Lentzen G, Drysdale M, Bower J, Potter AJ, Starkey ID, Swarbrick T, Aboul-ela F.

J Mol Biol. 2004 Feb 13;336(2):343-56.

PMID:
14757049
20.

In-hospital resource utilization in coronary angioplasty: the impact of increased coronary stenting rates and antiplatelet therapy.

Palmer ND, Fort S, Starkey IR, Shaw TR, Northridge DB.

Int J Cardiovasc Intervent. 2000 Sep;3(3):161-165.

PMID:
12470366
21.

An evaluation of Superthumb and the Kneeshaw device as manual therapy tools.

Maher CG, Latimer J, Starkey I.

Aust J Physiother. 2002;48(1):25-30.

22.

Outcomes following coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in the stent era: a prospective study of all 9890 consecutive patients operated on in Scotland over a two year period.

Pell JP, Walsh D, Norrie J, Berg G, Colquhoun AD, Davidson K, Eteiba H, Faichney A, Flapan A, Hogg KJ, Jeffrey RR, Jennings K, McArthur J, Mankad P, Oldroyd K, Pell AC, Starkey IR.

Heart. 2001 Jun;85(6):662-6.

23.

Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT)

Boden WE, van Gilst WH, Scheldewaert RG, Starkey IR, Carlier MF, Julian DG, Whitehead A, Bertrand ME, Col JJ, Pedersen OL, Lie KI, Santoni JP, Fox KM.

Lancet. 2000 May 20;355(9217):1751-6.

PMID:
10832825
25.

Outcome from a rapid-assessment chest pain clinic.

Davie AP, Caesar D, Caruana L, Clegg G, Spiller J, Capewell S, Starkey IR, Shaw TR, McMurray JJ.

QJM. 1998 May;91(5):339-43.

PMID:
9709467
26.

Characterisation of coronary atherosclerotic morphology by spectral analysis of radiofrequency signal: in vitro intravascular ultrasound study with histological and radiological validation.

Moore MP, Spencer T, Salter DM, Kearney PP, Shaw TR, Starkey IR, Fitzgerald PJ, Erbel R, Lange A, McDicken NW, Sutherland GR, Fox KA.

Heart. 1998 May;79(5):459-67.

27.

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.

Smith PW, Sollis SL, Howes PD, Cherry PC, Starkey ID, Cobley KN, Weston H, Scicinski J, Merritt A, Whittington A, Wyatt P, Taylor N, Green D, Bethell R, Madar S, Fenton RJ, Morley PJ, Pateman T, Beresford A.

J Med Chem. 1998 Mar 12;41(6):787-97.

PMID:
9526555
28.

Should use of intracoronary stents during percutaneous revascularisation be restricted?

Palmer N, Fort S, Starkey I, Shaw T, Northridge D.

Lancet. 1998 Feb 7;351(9100):416-7. No abstract available.

PMID:
9482299
29.

Do we have enough evidence to insist we have IVUS?

Starkey IR.

Heart. 1997 Oct;78 Suppl 2:30. No abstract available.

30.
31.

Characterisation of red and white thrombus by intravascular ultrasound using radiofrequency and videodensitometric data-based texture analysis.

Ramo MP, Spencer T, Kearney PP, Shaw ST, Starkey IR, McDicken WN, Fox KA.

Ultrasound Med Biol. 1997;23(8):1195-9.

PMID:
9372568
32.

A study of the quantitative and qualitative impact of catheter shaft angulation in a mechanical intravascular ultrasound system.

Kearney PP, Ramo MP, Spencer T, Shaw TR, Starkey IR, McDicken N, Sutherland GR.

Ultrasound Med Biol. 1997;23(1):87-93.

PMID:
9080621
33.

Analysis of reproducibility of reference lumen quantitation with intravascular ultrasound in stented coronary arteries.

Kearney PP, Ramo MP, Shaw TR, Starkey IR, McMurray JV, Sutherland GR.

Cathet Cardiovasc Diagn. 1997 Jan;40(1):1-7.

PMID:
8993807
34.

Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction.

Davie AP, Francis CM, Love MP, Caruana L, Starkey IR, Shaw TR, Sutherland GR, McMurray JJ.

BMJ. 1996 Jan 27;312(7025):222. No abstract available.

35.

How should a patient presenting with unstable angina and a recent stroke be managed?

Davenport RJ, Dennis MS, Sandercock PA, Warlow CP, Starkey IR, Ruckley CV, Porter JM, Jackson G, Ohman EM, Hornick P, et al.

BMJ. 1995 Jun 3;310(6992):1449-52. No abstract available.

37.

Intracoronary ultrasound: current state of the art.

Kearney PP, Starkey IR, Sutherland GR.

Br Heart J. 1995 May;73(5 Suppl 2):16-25. Review. No abstract available.

38.

Venous stenting as treatment for pacemaker-induced superior vena cava syndrome.

Francis CM, Starkey IR, Errington ML, Gillespie IN.

Am Heart J. 1995 Apr;129(4):836-7. No abstract available.

PMID:
7900642
39.

Open access echocardiography in management of heart failure in the community.

Francis CM, Caruana L, Kearney P, Love M, Sutherland GR, Starkey IR, Shaw TR, McMurray JJ.

BMJ. 1995 Mar 11;310(6980):634-6.

40.

A prospective study of left atrial spontaneous echo contrast and thrombus in 100 consecutive patients referred for balloon dilation of the mitral valve.

Rittoo D, Sutherland GR, Currie P, Starkey IR, Shaw TR.

J Am Soc Echocardiogr. 1994 Sep-Oct;7(5):516-27.

PMID:
7986549
41.
42.
43.

The RITA trial.

Starkey IR.

Lancet. 1993 Apr 17;341(8851):1020. No abstract available.

PMID:
8096894
44.
45.

Amiodarone and hair loss.

Samuel LM, Davie M, Starkey IR.

Postgrad Med J. 1992 Sep;68(803):771. No abstract available.

46.

Elderly and younger patients selected to undergo coronary angiography.

Elder AT, Shaw TR, Turnbull CM, Starkey IR.

BMJ. 1991 Oct 19;303(6808):950-3.

47.

Patients' observations of bioprosthetic valve failure: "my heart is honking, doctor".

Errington M, Bloomfield P, Starkey IR, Shaw TR.

Br Heart J. 1990 Dec;64(6):393-4.

48.

Predisposing factors for cerebral infarction: the Oxfordshire community stroke project.

Sandercock PA, Warlow CP, Jones LN, Starkey IR.

BMJ. 1989 Jan 14;298(6666):75-80.

49.

Infective endocarditis complicating tricuspid valve disease in the carcinoid syndrome.

Menzies DG, Campbell IW, Starkey IR.

Br Med J (Clin Res Ed). 1988 Mar 5;296(6623):682. No abstract available.

50.

Funny turns and cardiovascular disease.

Starkey IR.

Practitioner. 1987 May 8;231(1429):679-80, 682, 684-5. No abstract available.

PMID:
3422900

Supplemental Content

Loading ...
Support Center